Melanoma Clinical Trials
There are 24 registered clinical trials for Melanoma in the TrialLens index.
Trials (24)
- Immunological Variables Associated to ICI Toxicity in Cancer Patients Phase 2 · Jules Bordet Institute
- Nuclear and Near-Infrared (NIR) Imaging in Melanoma Phase 1 · M.D. Anderson Cancer Center
- Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies N/A · Regina Elena Cancer Institute
- Melanoma Perception and Health Literacy in People of Color N/A · Northwestern University
- Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. Phase 1 · Novartis Pharmaceuticals
- Nivolumab Plus Radiotherapy in Advanced Melanoma Phase 2 · Centre Hospitalier Universitaire de Nice
- Suicide Plus Immune Gene Therapy for Advanced Melanoma Early Phase 1 · Hospital Italiano de Buenos Aires
- Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells N/A · University of California, Davis
- Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma Phase 2 · Peking University Cancer Hospital & Institute
- SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma N/A · University of Texas Southwestern Medical Center
- A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor Phase 3 · GlaxoSmithKline
- Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030) N/A · Merck Sharp & Dohme LLC
- Pembrolizumab-PET Imaging N/A · University Medical Center Groningen
- A Study to Assess APO866 for the Treatment of Advanced Melanoma Phase 2 · Valerio Therapeutics
- Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma Phase 2 · University of Colorado, Denver
- 18F-FLT PET Imaging in Patients With Advanced Melanoma Phase 1 · Washington University School of Medicine
- Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions Phase 1 · Pfizer
- Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma Phase 3 · Shanghai Kechow Pharma, Inc.
- ATL001 in Patients With Metastatic or Recurrent Melanoma Phase 1/2 · Achilles Therapeutics UK Limited
- High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies N/A · M.D. Anderson Cancer Center
- Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer. N/A · Mayo Clinic
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1 · EMD Serono
- A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma Phase 2 · California Pacific Medical Center Research Institute
- Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma N/A · Hospices Civils de Lyon
Related landscapes
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.